Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.44	4.11	4.28	4.51	7.82	8.32
Cash & Short-Term Investments	7.44	4.11	4.28	4.51	7.82	8.32
Cash Growth	83.84%	-4.09%	-4.99%	-42.36%	-5.96%	-0.22%
Accounts Receivable	11.94	14.87	16.1	16.71	21.83	17.77
Receivables	11.94	14.87	16.1	16.71	21.83	17.77
Inventory	22.26	23.25	24.72	26.44	27.59	22.26
Other Current Assets	3.34	2.9	3.94	3.47	4.34	3.36
Total Current Assets	44.97	45.12	49.04	51.12	61.58	51.7
Property, Plant & Equipment	12.04	11.24	8.75	9.18	10.31	11.72
Long-Term Investments	-	-	3.5	-	-	-
Goodwill	10.15	56.32	57.07	56.26	57.69	58.59
Other Intangible Assets	9.14	11.13	16.04	21.01	27.39	33.15
Long-Term Deferred Tax Assets	-	0.09	0.44	0.33	0.21	0.26
Other Long-Term Assets	3.79	2.74	2.54	7.45	5.17	0.84
Total Assets	80.09	126.64	137.37	145.36	162.34	156.25
Accounts Payable	4.72	4.79	5.55	6.45	4.91	5.97
Accrued Expenses	2.83	2.26	4.43	3.87	6.53	4.15
Current Portion of Long-Term Debt	34.86	36.96	5.86	3.81	3.24	1.72
Current Portion of Leases	1.45	1.16	1.42	2.14	2.14	2.11
Current Income Taxes Payable	-	-	-	-	0.22	0.29
Current Unearned Revenue	3.14	3.81	4.51	3.37	4.27	3.77
Other Current Liabilities	8.19	5.99	4.78	3.62	4.01	3.05
Total Current Liabilities	55.2	54.96	26.54	23.25	25.32	21.05
Long-Term Debt	0.04	-	30.9	43.01	45.1	46.29
Long-Term Leases	7	6.38	4.79	5.28	6.49	7.48
Long-Term Deferred Tax Liabilities	0.73	0.71	0.78	0.59	1.56	1.9
Other Long-Term Liabilities	1.38	1.26	1.28	1.01	0.49	1.26
Total Liabilities	64.36	63.3	64.29	73.14	78.94	79.57
Common Stock	0.45	0.44	0.43	0.45	0.45	0.44
Additional Paid-In Capital	237.62	236.58	232.44	229.01	225.65	232.36
Retained Earnings	-210.63	-158.01	-145.61	-142.19	-132.67	-132.39
Treasury Stock	-	-	-	-	-	-10.67
Comprehensive Income & Other	-11.7	-15.67	-14.19	-15.05	-10.03	-13.07
Shareholders' Equity	15.73	63.34	73.07	72.22	83.4	76.68
Total Liabilities & Equity	80.09	126.64	137.37	145.36	162.34	156.25
Total Debt	43.36	44.5	42.97	54.24	56.96	57.6
Net Cash (Debt)	-35.92	-40.39	-35.19	-49.73	-49.14	-49.28
Net Cash Per Share	-0.82	-0.93	-0.83	-1.20	-1.22	-1.28
Filing Date Shares Outstanding	44.53	44.07	43.4	42.19	41.23	39.83
Total Common Shares Outstanding	44.53	44.07	43.39	42.08	41.14	39.41
Working Capital	-10.23	-9.84	22.5	27.88	36.27	30.65
Book Value Per Share	0.35	1.44	1.68	1.72	2.03	1.95
Tangible Book Value	-3.56	-4.12	-0.03	-5.05	-1.67	-15.06
Tangible Book Value Per Share	-0.08	-0.09	-0.00	-0.12	-0.04	-0.38
Machinery	-	18.36	15.95	15.71	15.3	18.02
Leasehold Improvements	-	2.57	2.42	2.51	2.56	2.54

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q